Brent L Saunders has bought stock on 8 days since Nov 2016

Brent L. Saunders (born 1970) is an American biopharmaceutical executive serving as Chairman and CEO of Bausch & Lomb Corporation (BLCO) since March 2023, his second tenure in the role after leading the company from 2010 to 2013, during which he oversaw its $8.7 billion acquisition by Valeant Pharmaceuticals (now Bausch Health).(

Saunders began his career as Chief Compliance Officer at Thomas Jefferson University Health System, advanced to Partner and Head of Compliance at PricewaterhouseCoopers, and held key roles at Schering-Plough, including President of Global Consumer Health Care and leading its merger with Merck.( He later served as CEO of Forest Laboratories (acquired by Actavis), CEO of Actavis (which merged with Allergan in a $70.5 billion deal), and Chairman, President, and CEO of Allergan until its $63 billion sale to AbbVie in 2020.( With over 20 years of experience, Saunders has orchestrated M&A deals exceeding $300 billion and currently chairs The Beauty Health Company and other innovation firms, while serving on boards like Cisco and contributing to healthcare accessibility.(

Written by Perplexity from public sources.